CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 155 enrolled
Drug / intervention
Clareon Vivity/Vivity Toric Extended Vision IOL +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05852470
NCT05852470N/ACompleted
CompareCT.gov

PMCF (Post Market Clinical Follow-up) Evaluation of Clareon Vivity/Vivity Toric

Alcon Research·interventional·Posted May 10, 2023·Updated Feb 24, 2026

In Brief

A clinical study evaluating Clareon Vivity/Vivity Toric Extended Vision IOL and Clareon Monofocal/Clareon Toric IOL for Aphakia. Completed, enrolled 155 participants across 7 sites.

Detailed Summary

This study seeks to generate clinical data from subjects previously implanted with the Clareon Vivity/Vivity Toric Intraocular Lenses (IOLs) or Clareon Monofocal/Clareon Toric IOLs. This study will assess key performance endpoints to support clinical benefits statements with model-specific data.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAphakia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedMay 10, 2023
Enrollment StartMay 23, 2023
Primary CompletionOct 27, 2023
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 3.1 years ago

Interventions

Clareon Vivity/Vivity Toric Extended Vision IOLdevice

Extended vision intraocular lens implanted in the capsular bag of the eye during cataract surgery. IOLs are intended for long term use over the lifetime of the cataract patient.

Clareon Monofocal/Clareon Toric IOLdevice

Single vision intraocular lens implanted in the capsular bag of the eye during cataract surgery. IOLs are intended for long term use over the lifetime of the cataract patient.